Loading…
← CockpitCompetitor Analysis › NHC National HealthCare CorporationOpen in the cockpit ↗

National HealthCare CorporationNHCCompetitor analysis, valuation and peers

United States · USD·Health Care›Hospital/Nursing Management

Operates skilled nursing, assisted living, home health and hospice facilities concentrated in Tennessee and the Southeast.

Momentum weak 35
Mkt cap
$3.16B
US dollars, full cap
Free float
81%
of shares outstanding
$/day
$34.3M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-8.3 pp
WACC 7.9%
Hurdle
-3 pp
Req g minus delivered
Close · USD$201.60
1D-2.0%
1W-4.2%
1M-18.7%
3M-14.8%
6M+1.1%
YTD+47.1%
1Y+60.2%
ATR %3.5%
Beta0.24
52w lowhigh18.8% off high

What National HealthCare does

Operates skilled nursing, assisted living, home health and hospice facilities concentrated in Tennessee and the Southeast.

Is paid daily rates for each resident or patient, mostly by Medicare and Medicaid, so government reimbursement rates and occupancy decide results; private-pay residents in assisted living add higher-paying income. State licensing limits on new beds protect existing centres.

Products and services

  • Skilled nursing centers
  • Assisted living
  • Home health/hospice
  • Behavioral health

Customers

  • Medicare/Medicaid patients
  • Private-pay residents
  • Hospital referral networks

Where it sits in the supply chain

  • Healthcare services
  • Post-acute and long-term care
  • Skilled nursing/assisted living…

What could go right

  • Aging population demand
  • Occupancy recovery post-pandemic

What could go wrong

  • Medicare/Medicaid reimbursement risk
  • Labor cost and staffing shortages

Moat: narrow (regulatory licence, scale, brand). State certificate-of-need licensing and a long-standing regional operating reputation limit new entry.

Headquarters: Murfreesboro, Tennessee, United States · Founded: 1971 · Employees: 15,278

Named competitors

National HealthCare at a glance

Size National HealthCare (NHC) is a United States Health Care company (Hospital/Nursing Management) with a market value of $3.16B, the 1497th largest of 3,085 United States companies the cockpit tracks. Shares closed at $201.60 on 18 Nov 2026.

Performance Over six months the shares gained 1.1%, against -2.3% for the median peer and -2.2% for the United States market (cap-weighted) — 9th highest of 21 in its peer set.

Growth Revenue grew 5.7% over the last twelve months (peer median +12.9%); the operating margin is -0.4% (peer median 11.0%).

Valuation It trades at 2.2× enterprise value to sales against a peer median of 3.0× (8th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about 6% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 8.3 points below its cost of capital (7.9% WACC).

Short interest Short interest is 4.9% of the free float (30 Oct 2026).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026NHC 103Peer median 97
Six months, rebased to 100: National HealthCare against the median of its 20 peers (local-currency closes).

National HealthCare financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.58B$1.51B$1.25B$1.12B$1.05B
Revenue growth—+21%+12%+6%—
Gross profit$999M$1.07B$880M$772M$709M
EBITDA$42.9M$188M$107M$88.0M$26.2M
Net income$115M$120M$102M$66.8M$22.4M
Free cash flow$176M$149M$79.7M$83.3M-$21.5M
Capital expenditure$101M$36.4M$27.6M$27.9M$30.2M
Total debt$518M$87.1M$215M$93.4M$126M

Quarterly statements and history in the cockpit →

National HealthCare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%0%+20%KIMSSGRYMEDANTANH600763BKDARDTEXE301267SIAASTERDM000516AEVSCHEPACS301293SPINHC6-month return →1-month return →
Up and to the right = strong over both horizons. National HealthCare is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%2×4×6×8×KIMSSGRYMEDANTANH600763BKDARDTEXE301267SIAFORTISASTERDM000516AEVSCHERAINBOWPACS301293BSLNHCRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. National HealthCare is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%SGRYNH600763BKDARDTEXE301267SIAFORTISASTERDM000516AEVSCHERAINBOWPACSSPIBSLNHCGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. National HealthCare is the large dot.

National HealthCare competitors and peer comparison

Head to head with its named competitors (NHC vs BKD vs ENSG vs PNTG)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
National HealthCare NHC$3.16B+1%+6%0%2.2×6.4%
Brookdale Senior Living BKD$2.06B-36%-8%6%2.4×19.3%
Ensign ENSG$10.7B+3%+17%9%2.2×12.7%
Pennant PNTG$1.26B+1%+39%6%1.5×20.7%
Sonida Senior Living SNDA$1.59B-11%+70%-8%4.8×n/a
Chemed CHE$7.12B+24%+5%14%2.8×3.3%
Addus HomeCare ADUS$2.25B+29%+12%11%1.5×4.0%

How National HealthCare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

National HealthCare against its 20 peers (data as of 18 Nov 2026)
MeasureNHCPeer medianRank in peer set
1-month return-18.7%+3.3%lowest of 21
6-month return+1.1%-2.3%9th highest of 21
Distance from 52-week high-18.8%-19.7%11th highest of 21
Revenue growth (TTM)+5.7%+12.9%9th lowest of 21
Operating margin-0.4%11.0%3rd lowest of 21
EV / Sales2.2×3.0×8th cheapest of 21
Growth the price implies (Req g, 7 yrs)6.4%12.7%5th least demanding of 18
Growth delivered (Del g)+9.7%+10.2%9th lowest of 18
Hurdle (Req g minus delivered)-3.3 pp+3.4 pp6th least demanding of 18
ROIC minus cost of capital-8.3 pp-1.2 pp2nd lowest of 21
Net debt / EBITDA5.6×2.8×5th most indebted of 17

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
National HealthCare NHCUnited States$3.16B+1%+6%0%2.2×6.4%+9.7%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%7.7×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%2.4×15.6%+12.2%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%7.6×n/an/a
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%4.1×31.2%+25.0%
Topchoice Medical 600763.SSChina$2.33B-12%+7%26%5.3×12.4%+6.9%
Brookdale Senior Living BKDUnited States$2.06B-36%-8%6%2.4×19.3%-1.4%
Ardent Health ARDTUnited States$2.03B+52%+2%5%0.6×-1.7%+8.7%
Extendicare EXE.TOCanada$1.91B-16%+36%9%1.5×10.8%+8.5%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%2.1×2.1%+10.4%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%3.1×18.9%+8.6%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%6.3×42.5%+17.9%
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%10.6×48.6%-11.6%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%3.1×12.7%+20.6%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%1.8×26.5%+10.2%
Chemed CHEUnited States$7.12B+24%+5%14%2.8×3.3%+4.0%
Rainbow Childrens Medicare RAINBOW.NSIndia$1.37B-7%+23%22%7.0×30.7%+21.2%
PACS PACSUnited States$7.35B+25%+11%8%1.9×7.5%+29.7%
Sanbo Hospital Management 301293.SZChina$1.35B-29%+17%6%4.9×n/an/a
Spire Healthcare SPI.LUnited Kingdom$1.31B+11%+2%8%1.4×10.0%+11.4%
Raffles Medical BSL.SISingapore$1.23B-13%-3%11%1.8×-2.7%+6.1%

Questions

Who are National HealthCare's main competitors?
Named competitors: Brookdale Senior Living (BKD), Ensign Group (ENSG), Diversicare Healthcare (private or unlisted), Pennant Group (PNTG), Sonida Senior Living (SNDA), Chemed (VITAS Healthcare) (CHE). The cockpit's measured peer set (industry) also includes Krishna Institute of Medical Sciences (KIMS.NS), Surgery Partners (SGRY), Global Health (MEDANTA.NS), Narayana Hrudayalaya (NH.NS), Topchoice Medical (600763.SS), Brookdale Senior Living (BKD).
Is National HealthCare expensive compared with its peers?
On ev / sales it trades at 2.2× against a peer median of 3.0×, 8th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about 6% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has National HealthCare stock performed?
Over six months to 18 Nov 2026 the shares returned +1.1% against -2.3% for the median peer; over one year +60.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.